GeneCentric Therapeutics Raises $8 Million in Series C Funding Round

Hatteras Venture Partners leads the funding round as GeneCentric secures $8 million to advance precision medicine through gene expression.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here